Navigation Links
Cepheid Reports Third Quarter Revenue of $44.9 Million
Date:10/28/2008

GeneXpert(R) System Momentum Drives 71% Year-Over-Year Growth in Core

Clinical Business

SUNNYVALE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the third quarter of 2008 of $44.9 million, an increase of 24% over the third quarter of fiscal 2007. Net loss was $6.5 million, or $(0.11) per share, which compares to revenue of $36.3 million and a net loss of $4.7 million, or $(0.09) per share, in the third quarter of fiscal 2007.

Excluding amortization of purchased intangible assets and stock compensation expenses, non-GAAP net loss for the third quarter was $2.3 million, or $(0.04) per share. This compares to a non-GAAP net loss of $1.5 million, or $(0.03) per share, in the third quarter of fiscal 2007.

"With very strong North American system placements and record MRSA test revenue, our third quarter results highlight the continued momentum of Cepheid's industry-leading GeneXpert System," said John Bishop, Cepheid's Chief Executive Officer. "Approximately 74% of North American system placements in the third quarter were various configurations of our GX-16 which should help to position accounts to take full advantage of our rapidly-developing test menu. With the two additional Xpert(TM) tests cleared by the FDA within the last month, and an aggressive development pipeline that expands beyond Healthcare Associated Infections into women's health, critical infectious disease and oncology, our GeneXpert System is rapidly earning its reputation as the molecular platform of choice for on-demand testing."

Operational Overview

-- Total product sales increased 25% to $42.4 million, from $34.0 million

in the third quarter of fiscal 2007. By industry, product sales were,

in millions:

Three Months Ended September 30

2008 2007 Change

Core Clinical
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
2. Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized Moderate Complexity by FDA
3. Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
4. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
5. Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
6. Cepheid to Webcast Upcoming Financial Presentations
7. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
8. Cepheid Reports Second Quarter Revenue of $42.1 Million
9. Cepheid to Webcast Analyst Event
10. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
11. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... --   First published articles ... Elsevier , a world-leading provider of scientific, technical and ... launch of the latest title in the Current Opinion ... Science . Current Opinion ... platform to keep up-to-date with the expanding volume of information ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 Continental ... patient populations into clinical trials at its mid-Atlantic ... , “Continental was created with the idea of ... a fundamental role in medical advances," said Continental's ... syphilis experiment to the immortal cell line of ...
(Date:11/24/2014)... , Nov. 24, 2014  Spherix Incorporated ... company committed to the fostering and monetization of ... v. VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  ... No. 3:13-cv-03496-M, both in the United States District ... Texas . On November ...
(Date:11/22/2014)... November 21, 2014 Two new educational webinars ... comes next for ALS research and how the pharmaceutical industry ... the Ice Bucket Challenge: Where Does the ALS Money Go? ... 2 December 2014, Time: 1:30pm ET, Register to ... speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology at ...
Breaking Biology Technology:Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2
... introduced the world to tiny robots demonstrating soccer ... competition designed to advance microroboticsthe field devoted to ... dimensions are measured in micrometers (millionths of a ... Technology (NIST), in collaboration with IEEE, is inviting ...
... While other states jockeyed for position on Business ... its ranking as best in the Midwest and No. ... bioscience industry . , (Logo: ... bioscience ranking is in part due to updated estimates ...
... A faster tool for cell programming and a new way ... prizes of the 2009 Collegiate Inventors Competition, a program of ... Fund, the non-profit foundation of the global health care company ... Harris Wang, who invented a new way of cell ...
Cached Biology Technology:Is your microrobot up for the (NIST) challenge? 2Ohio Bioscience Industry Leads Midwest, Among Best in Nation as Investment Destination 2Winners Announced in 2009 Collegiate Inventors Competition(R) 2Winners Announced in 2009 Collegiate Inventors Competition(R) 3Winners Announced in 2009 Collegiate Inventors Competition(R) 4Winners Announced in 2009 Collegiate Inventors Competition(R) 5Winners Announced in 2009 Collegiate Inventors Competition(R) 6Winners Announced in 2009 Collegiate Inventors Competition(R) 7
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
(Date:11/10/2014)... began appearing on U.S. store shelves in early 2010, ... since. The small packets can be tossed into a ... liquid or powder. The convenience, though, has come with ... researchers at Nationwide Children,s Hospital found that from 2012 ... 17,230 children younger than 6 years of age swallowing, ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2
... suggests that a blood clot-dissolving medication that is administered ... may help to reduce the risk of amputation following ... issue of Archives of Surgery, one of the JAMA/Archives ... for the past 25 years, according to background information ...
... nanoparticle made in a laboratory at the University of ... device for treating glaucoma, an eye disease that can ... “The nanoparticle can safely get past the blood-brain barrier ... said Sudipta Seal, an engineering professor with appointments in ...
... of infections and other diseases of the brain is ... from reaching the brain. Grantees of the National Institute ... Institutes of Health, have now shown that a short ... strip of therapeutic material into the brain via intravenous ...
Cached Biology News:Clot-dissolving agent may be beneficial in treatment of severe frostbite 2UCF nanoparticle offers promise for treating glaucoma 2Blood-brain barrier breached by new therapeutic strategy 2
... be used to test the crossreactivity of ... that are commonly used as blocking reagents ... for 19 different protein preparations on a ... and species specificity, QC of purified antibodies, ...
... HydroFlex platform provides excellent performance, reliability ... 96-well format applications, including washing of ... and vacuum filtration-to-waste, such as for ... control features set new standards for ...
... Obtain Clean and Accurate Results Laser ... increase the sensitivity and accuracy of molecular ... cell types and multi-cellular structures isolated from ... approach to microdissection-developed in 1996 at the ...
...
Biology Products: